Literature DB >> 9032810

Stromal differentiation and architecture of the human umbilical cord.

A K Nanaev1, G Kohnen, A P Milovanov, S P Domogatsky, P Kaufmann.   

Abstract

In order to assess the characteristics of its stromal cells and the distribution of extracellular matrix proteins, we investigated, immunohistochemically and ultrastructurally, term, first and second trimester human umbilical cords. A differential distribution pattern of the various cytoskeletal proteins of stromal cells and extracellular matrix proteins was observed in different zones of the stroma, the subamniotic stroma, Wharton's jelly, and the vessels' adventitia. All three zones showed immunoreactivities for collagen types I, III and VI and for basement membrane molecules such as collagen type IV, laminin and heparan sulphate proteoglycan. Immunoreactivities for these extracellular matrix molecules were observed around cleft-like territories (stromal clefts) in the Wharton's jelly which were occupied by homogeneous ground substance but void of collagen fibrils and basal lamina molecules. Moreover, between the stromal clefts, slender cells were found which immunohistochemically and ultrastructurally corresponded to various stages of myofibroblastic differentiation. In earlier stages of gestation, stromal cells with a less complex expression pattern prevailed. The stromal clefts and the contractile cells together might serve as a system regulating the turgor of the cord.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032810     DOI: 10.1016/s0143-4004(97)90071-0

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  32 in total

1.  [Umbilical cord stromal cells (UCSC). Cells featuring osteogenic differentiation potential].

Authors:  M Eblenkamp; J Aigner; J Hintermair; S Potthoff; U Hopfner; V Jacobs; M Niemeyer; E Wintermantel
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

Review 2.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

3.  Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord.

Authors:  Ikuo Ishige; Tokiko Nagamura-Inoue; Masaki J Honda; Ratanakanit Harnprasopwat; Michiko Kido; Mitsuhiro Sugimoto; Hiromitsu Nakauchi; Arinobu Tojo
Journal:  Int J Hematol       Date:  2009-08-06       Impact factor: 2.490

4.  Absence of Wharton's jelly around the umbilical arteries.

Authors:  M L Kulkarni; Prakash S Matadh; C Ashok; N Pradeep; T Avinash; Akhil M Kulkarni
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

5.  Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix.

Authors:  B Corradetti; A Lange-Consiglio; M Barucca; F Cremonesi; D Bizzaro
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

Review 6.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 7.  The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.

Authors:  Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

8.  Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.

Authors:  Arianna Barbara Lovati; Bruna Corradetti; Anna Lange Consiglio; Camilla Recordati; Elisa Bonacina; Davide Bizzaro; Fausto Cremonesi
Journal:  Vet Res Commun       Date:  2010-12-31       Impact factor: 2.459

9.  Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord.

Authors:  Sachin S Kadam; Shubha Tiwari; Ramesh R Bhonde
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-12-05       Impact factor: 2.416

10.  The human umbilical vein with Wharton's jelly as an allogeneic, acellular construct for vocal fold restoration.

Authors:  Roger W Chan; Maritza L Rodriguez; Peter S McFetridge
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.